Cargando…

Effective Amelioration of Liver Fibrosis Through Lentiviral Vector Carrying Toxoplasma gondii gra15(II) in Murine Model

Our previous investigations indicated that in vitro polarization of mouse macrophages by Toxoplasma gondii type (II) strain dense granule protein 15 (GRA15(II)), one of the genotype-associated effectors of T. gondii, induced the phenotypes of classically activated macrophage (M1). Transfusion of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lei, Jin, Mengmeng, Tao, Qing, Yu, Li, Du, Jian, Wang, Cong, Luo, Qingli, Xing, Tian, Xu, Yuanhong, Shen, Jilong, Chu, Deyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043635/
https://www.ncbi.nlm.nih.gov/pubmed/30034399
http://dx.doi.org/10.3389/fimmu.2018.01572
_version_ 1783339322264518656
author Liu, Lei
Jin, Mengmeng
Tao, Qing
Yu, Li
Du, Jian
Wang, Cong
Luo, Qingli
Xing, Tian
Xu, Yuanhong
Shen, Jilong
Chu, Deyong
author_facet Liu, Lei
Jin, Mengmeng
Tao, Qing
Yu, Li
Du, Jian
Wang, Cong
Luo, Qingli
Xing, Tian
Xu, Yuanhong
Shen, Jilong
Chu, Deyong
author_sort Liu, Lei
collection PubMed
description Our previous investigations indicated that in vitro polarization of mouse macrophages by Toxoplasma gondii type (II) strain dense granule protein 15 (GRA15(II)), one of the genotype-associated effectors of T. gondii, induced the phenotypes of classically activated macrophage (M1). Transfusion of the cells to mice may effectively alleviated hepatic fibrosis caused by schistosomiasis. The purpose of the study was to identify whether liver macrophages can be in vivo driven to M1 macrophages by lentiviral vector (LV) carrying GRA15(II) gene (LV-gra15(II)) and to explore the potential mechanism by which the LV-gra15(II)-activated liver macrophage (LV-gra15(II)-M) ameliorates the hepatic fibrosis in schistosomiasis. The mice were treated with LV-gra15(II) by hydrodynamic injection via the tail vein followed by challenge of Schistosoma japonicum (S. japonicum). Our experiments showed that LV-gra15(II) was successfully delivered to liver macrophages and GRA15(II) was persistently expressed in the macrophages of mice for at least 2 months. Furthermore, the LV-gra15(II) infected macrophages were polarized to M1 macrophages in vivo. Consequently, mice with schistosomiasis receiving LV-gra15(II) injection displayed a remarkable amelioration of liver granuloma formation and collagen deposition in association with downregulated expression of transforming growth factor-beta1, arginase 1 (Arg-1), α-smooth muscle actin, and an increased expression of matrix metalloproteinase 13 (MMP13). Simultaneously, no negative effects of liver function and vitality of mice were noted. The in vitro experiments indicated that the C-C motif chemokine ligand 2 and nitric oxide level were elevated in LV-gra15(II)-M cultural supernatants; hepatocyte growth factor expression was enhanced in LV-gra15(II)-M. In addition, LV-gra15(II)-M not only secreted MMP13, which greatly degraded type (I) collagen, but also induced murine hepatic stellate cell (HSC) line (JS1) apoptosis in the co-culture system. Taken together, we identified for the first time that LV-gra15(II) may in vivo drive liver macrophages to M1 macrophage phenotypes, which helps for alteration of the liver fibrotic microenvironment with collagen dissolution, HSC deactivation, apoptosis and hepatocyte protection. Our study gives an insight into the use of gene delivery with parasite-derived immunomodulatory factor as a potential immune cell activating agent to re-equilibrate the other pathogen-induced immune response in some chronic diseases.
format Online
Article
Text
id pubmed-6043635
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-60436352018-07-20 Effective Amelioration of Liver Fibrosis Through Lentiviral Vector Carrying Toxoplasma gondii gra15(II) in Murine Model Liu, Lei Jin, Mengmeng Tao, Qing Yu, Li Du, Jian Wang, Cong Luo, Qingli Xing, Tian Xu, Yuanhong Shen, Jilong Chu, Deyong Front Immunol Immunology Our previous investigations indicated that in vitro polarization of mouse macrophages by Toxoplasma gondii type (II) strain dense granule protein 15 (GRA15(II)), one of the genotype-associated effectors of T. gondii, induced the phenotypes of classically activated macrophage (M1). Transfusion of the cells to mice may effectively alleviated hepatic fibrosis caused by schistosomiasis. The purpose of the study was to identify whether liver macrophages can be in vivo driven to M1 macrophages by lentiviral vector (LV) carrying GRA15(II) gene (LV-gra15(II)) and to explore the potential mechanism by which the LV-gra15(II)-activated liver macrophage (LV-gra15(II)-M) ameliorates the hepatic fibrosis in schistosomiasis. The mice were treated with LV-gra15(II) by hydrodynamic injection via the tail vein followed by challenge of Schistosoma japonicum (S. japonicum). Our experiments showed that LV-gra15(II) was successfully delivered to liver macrophages and GRA15(II) was persistently expressed in the macrophages of mice for at least 2 months. Furthermore, the LV-gra15(II) infected macrophages were polarized to M1 macrophages in vivo. Consequently, mice with schistosomiasis receiving LV-gra15(II) injection displayed a remarkable amelioration of liver granuloma formation and collagen deposition in association with downregulated expression of transforming growth factor-beta1, arginase 1 (Arg-1), α-smooth muscle actin, and an increased expression of matrix metalloproteinase 13 (MMP13). Simultaneously, no negative effects of liver function and vitality of mice were noted. The in vitro experiments indicated that the C-C motif chemokine ligand 2 and nitric oxide level were elevated in LV-gra15(II)-M cultural supernatants; hepatocyte growth factor expression was enhanced in LV-gra15(II)-M. In addition, LV-gra15(II)-M not only secreted MMP13, which greatly degraded type (I) collagen, but also induced murine hepatic stellate cell (HSC) line (JS1) apoptosis in the co-culture system. Taken together, we identified for the first time that LV-gra15(II) may in vivo drive liver macrophages to M1 macrophage phenotypes, which helps for alteration of the liver fibrotic microenvironment with collagen dissolution, HSC deactivation, apoptosis and hepatocyte protection. Our study gives an insight into the use of gene delivery with parasite-derived immunomodulatory factor as a potential immune cell activating agent to re-equilibrate the other pathogen-induced immune response in some chronic diseases. Frontiers Media S.A. 2018-07-06 /pmc/articles/PMC6043635/ /pubmed/30034399 http://dx.doi.org/10.3389/fimmu.2018.01572 Text en Copyright © 2018 Liu, Jin, Tao, Yu, Du, Wang, Luo, Xing, Xu, Shen and Chu. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Liu, Lei
Jin, Mengmeng
Tao, Qing
Yu, Li
Du, Jian
Wang, Cong
Luo, Qingli
Xing, Tian
Xu, Yuanhong
Shen, Jilong
Chu, Deyong
Effective Amelioration of Liver Fibrosis Through Lentiviral Vector Carrying Toxoplasma gondii gra15(II) in Murine Model
title Effective Amelioration of Liver Fibrosis Through Lentiviral Vector Carrying Toxoplasma gondii gra15(II) in Murine Model
title_full Effective Amelioration of Liver Fibrosis Through Lentiviral Vector Carrying Toxoplasma gondii gra15(II) in Murine Model
title_fullStr Effective Amelioration of Liver Fibrosis Through Lentiviral Vector Carrying Toxoplasma gondii gra15(II) in Murine Model
title_full_unstemmed Effective Amelioration of Liver Fibrosis Through Lentiviral Vector Carrying Toxoplasma gondii gra15(II) in Murine Model
title_short Effective Amelioration of Liver Fibrosis Through Lentiviral Vector Carrying Toxoplasma gondii gra15(II) in Murine Model
title_sort effective amelioration of liver fibrosis through lentiviral vector carrying toxoplasma gondii gra15(ii) in murine model
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043635/
https://www.ncbi.nlm.nih.gov/pubmed/30034399
http://dx.doi.org/10.3389/fimmu.2018.01572
work_keys_str_mv AT liulei effectiveameliorationofliverfibrosisthroughlentiviralvectorcarryingtoxoplasmagondiigra15iiinmurinemodel
AT jinmengmeng effectiveameliorationofliverfibrosisthroughlentiviralvectorcarryingtoxoplasmagondiigra15iiinmurinemodel
AT taoqing effectiveameliorationofliverfibrosisthroughlentiviralvectorcarryingtoxoplasmagondiigra15iiinmurinemodel
AT yuli effectiveameliorationofliverfibrosisthroughlentiviralvectorcarryingtoxoplasmagondiigra15iiinmurinemodel
AT dujian effectiveameliorationofliverfibrosisthroughlentiviralvectorcarryingtoxoplasmagondiigra15iiinmurinemodel
AT wangcong effectiveameliorationofliverfibrosisthroughlentiviralvectorcarryingtoxoplasmagondiigra15iiinmurinemodel
AT luoqingli effectiveameliorationofliverfibrosisthroughlentiviralvectorcarryingtoxoplasmagondiigra15iiinmurinemodel
AT xingtian effectiveameliorationofliverfibrosisthroughlentiviralvectorcarryingtoxoplasmagondiigra15iiinmurinemodel
AT xuyuanhong effectiveameliorationofliverfibrosisthroughlentiviralvectorcarryingtoxoplasmagondiigra15iiinmurinemodel
AT shenjilong effectiveameliorationofliverfibrosisthroughlentiviralvectorcarryingtoxoplasmagondiigra15iiinmurinemodel
AT chudeyong effectiveameliorationofliverfibrosisthroughlentiviralvectorcarryingtoxoplasmagondiigra15iiinmurinemodel